| Specimen requirement |
Adult patient:
Number of vials: 2 Minimum blood volume: 6 mL |
|||||||||||||||||||
|
Paediatric patient: Paediatric EDTA tube Number of vials: 3 Minimum blood volume: 3.9 mL |
||||||||||||||||||||
| Authorisation code required | No | |||||||||||||||||||
| 24 Hr available service | No | |||||||||||||||||||
| Precaution |
Refer to protocol for investigation of primary hyperaldosteronism (renin-aldosterone test) for patient preparations. |
|||||||||||||||||||
| Method | Liquid chromatography-tandem mass spectrometry | |||||||||||||||||||
| Reference interval |
| |||||||||||||||||||
| Clinical indication | Investigation of hypertension when primary hyperaldosteronism or unilateral renal disease is suspected. Assessing adequacy of mineralocorticoid replacement Management of congenital adrenal hyperplasia |
|||||||||||||||||||
| Result interpretation |
The plasma aldosterone / renin ratio is of greater diagnostic value than either test alone. A high aldosterone / renin ratio suggests a mineralocorticoid abnormality. Elevation of both aldosterone and renin to a similar extent suggests a renal abnormality. Lateralising studies are done in suspected unilateral renal ischaemia or renal artery stenosis. In congenital adrenal hyperplasia, excessive levels indicate inadequate mineralocorticoid replacement. |
|||||||||||||||||||
| Measurement of uncertainty | See table. | |||||||||||||||||||
| Frequency of measurement | Biweekly |